We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

69 hedge funds and large institutions have $270M invested in Albireo Pharma Inc in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

75% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 12

38% more funds holding

Funds holding: 50 → 69 (+19)

27% more capital invested

Capital invested by funds: $213M → $270M (+$56.6M)

Holders
69
Holders Change
+19
Holders Change %
+38%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
21
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14.5M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$8.95M
3
State Street
State Street
Massachusetts
+$4.54M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$3.49M
5
Northern Trust
Northern Trust
Illinois
+$2.72M

Top Sellers

Rank Fund Capital Flow
1
AWG
Alpha Wave Global
New York
-$5.7M
2
DZ Bank
DZ Bank
Germany
-$2.04M
3
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$1.97M
4
Millennium Management
Millennium Management
New York
-$1.67M
5
AG
Artal Group
Luxembourg
-$1.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.08M +$986K +30,443 New
TCIM
27
TIAA CREF Investment Management
New York
$928K +$847K +26,137 New
VEA
28
Virtus ETF Advisers
New York
$876K +$800K +24,688 New
Prudential Financial
29
Prudential Financial
New Jersey
$820K +$748K +23,077 New
Deutsche Bank
30
Deutsche Bank
Germany
$813K +$739K +22,816 +22,816%
PPA
31
Parametric Portfolio Associates
Washington
$740K +$145K +4,485 +27%
Morgan Stanley
32
Morgan Stanley
New York
$703K +$361K +11,154 +129%
Charles Schwab
33
Charles Schwab
California
$679K +$619K +19,099 New
EP
34
Eversept Partners
New York
$640K – – –
TA
35
Teachers Advisors
New York
$618K +$564K +17,401 New
AA
36
ALPS Advisors
Colorado
$613K +$559K +17,257 New
AAP
37
Ardsley Advisory Partners
Connecticut
$536K -$32.4K -1,000 -6%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$495K +$452K +13,940 New
JMH
39
J.M. Hartwell
New York
$476K +$107K +3,300 +33%
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$476K +$434K +13,402 New
EMG
41
Ellington Management Group
Connecticut
$444K +$405K +12,500 New
UBS Group
42
UBS Group
Switzerland
$398K +$67.3K +2,077 +23%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$362K +$330K +10,200 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$335K +$306K +9,438 New
DS
45
DRW Securities
Illinois
$320K +$292K +9,000 New
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$269K +$234K +7,221 +2,057%
Goldman Sachs
47
Goldman Sachs
New York
$214K -$1.49M -46,082 -88%
AIG
48
American International Group
New York
$211K +$192K +5,935 New
MIM
49
MetLife Investment Management
New Jersey
$167K +$153K +4,713 New
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
$165K +$150K +4,645 New
1
2
3 4

ALBO Hedge Fund Activity: Q2 2018 in Review

69 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2018, worth a combined $270M — up 27% from $213M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ALBO positions and 8 closed out — a net gain of 19 holders — while 21 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $5.7M sold.

  • 69 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2018, up from 50 in Q1 2018.
  • Funds reported $270M of Albireo Pharma Inc stock for Q2 2018, up 27% quarter-over-quarter.
  • 27 funds opened new Albireo Pharma Inc positions in Q2 2018 and 8 closed out, a net change of +19 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2018 was BlackRock, an estimated $14.5M added.
  • The largest Albireo Pharma Inc seller in Q2 2018 was Alpha Wave Global, an estimated $5.7M sold.

Based on aggregated 13F filings for Q2 2018.